The abuse potential of cocaine, amphetamine and related psychostimulants result from a direct interaction of these substances with the Na+/CI- dependent biogenic amine transporters. These transporters mediate rapid reuptake of biogenic amines from the synaptic cleft and include the transporters for dopamine (DAT), norepinephrine and serotonin. The long term goal of the present proposal is to understand the molecular and cellular mechanisms governing the activity and availability of this class of transporters in the presynaptic membrane and how this is modulated by endogenous substrate and by drugs of abuse. Insight into these mechanisms has a strong potential of unrevealing new therapeutical strategies for both drug abuse and psychiatric disorders. In this grant we propose to test the hypothesis that the C-terminus of the DAT serves multiple distinct roles in the regulation of endoplasmic reticulum (ER) export, targeting, internalization, recycling, degradation, and phosphorylation of the transporter. The extreme C-terminus of DAT contains a type 2 PDZ (PSD-95/Discs-large/ZO-1 homology) binding sequence shown to interact with the PDZ domain protein PICK1. Deletion of this PDZ binding sequence (Leu-Lys-Val) leads to retention of DAT in the ER, and it has been assumed, therefore, that interactions with PDZ proteins are critical for ER export and surface targeting. However, based on analysis of C-terminal DAT mutations, we have shown that although the extreme C-terminus of the DAT is indispensable for ER export and surface targeting, these processes do not appear to require PDZ domain interactions. Instead we surmise a key role of PDZ domain interactions for regulating transporter trafficking and phosphorylation as well as a role of non-PDZ mediated interactions for ER export. We will test these hypotheses by utilizing the unique ensemble of expertises available in the PPG group. Moreover, we will continue to develop and apply advanced fluorescence technologies in the proposed studies both within this component and in collaboration with the other components of the PPG.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA012408-09
Application #
7406010
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2008-01-01
Budget End
2008-12-31
Support Year
9
Fiscal Year
2007
Total Cost
$191,453
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Mayer, Felix P; Schmid, Diethart; Owens, W Anthony et al. (2018) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology 43:2408-2417
Quick, Matthias; Abramyan, Ara M; Wiriyasermkul, Pattama et al. (2018) The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites. Proc Natl Acad Sci U S A 115:E7924-E7931
Herborg, Freja; Andreassen, Thorvald F; Berlin, Frida et al. (2018) Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. J Biol Chem 293:7250-7262
Razavi, Asghar M; Khelashvili, George; Weinstein, Harel (2018) How structural elements evolving from bacterial to human SLC6 transporters enabled new functional properties. BMC Biol 16:31
Doktorova, Milka; Weinstein, Harel (2018) Accurate In Silico Modeling of Asymmetric Bilayers Based on Biophysical Principles. Biophys J 115:1638-1643
LeVine, Michael V; Cuendet, Michel A; Razavi, Asghar M et al. (2018) Thermodynamic Coupling Function Analysis of Allosteric Mechanisms in the Human Dopamine Transporter. Biophys J 114:10-14
Stolzenberg, Sebastian; Li, Zheng; Quick, Matthias et al. (2017) The role of transmembrane segment 5 (TM5) in Na2 release and the conformational transition of neurotransmitter:sodium symporters toward the inward-open state. J Biol Chem 292:7372-7384
Razavi, Asghar M; Khelashvili, George; Weinstein, Harel (2017) A Markov State-based Quantitative Kinetic Model of Sodium Release from the Dopamine Transporter. Sci Rep 7:40076
Sahai, Michelle A; Davidson, Colin; Khelashvili, George et al. (2017) Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB. Prog Neuropsychopharmacol Biol Psychiatry 75:1-9
Gregorio, G Glenn; Masureel, Matthieu; Hilger, Daniel et al. (2017) Single-molecule analysis of ligand efficacy in ?2AR-G-protein activation. Nature 547:68-73

Showing the most recent 10 out of 146 publications